🇺🇸 FDA
Patent

US 11952419

Reagents and methods for treating cancer and autoimmune disease

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 11952419 (Reagents and methods for treating cancer and autoimmune disease) held by UNIVERSITY OF CONNECTICUT expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue Apr 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K38/00, A61P